Immune checkpoint inhibitors: a physiology-driven approach to the treatment of coronavirus disease 2019

Por Di Cosimo, Serena, Malfettone, Andrea, Pérez-García, José M., Llombart-Cussac, Antonio, Miceli, Rosalba, Curigliano, Giuseppe, Cortés, Javier
Publicado no Eur J Cancer (2020)

Role of RAS mutation status as a prognostic factor for patients with advanced colorectal cancer treated with first-line chemotherapy based on fluoropyrimidines and oxaliplatin, wit...

Por Garde Noguera, Javier, Jantus-Lewintre, Eloisa, Gil-Raga, Mireia, Evgenyeva, Elena, Maciá Escalante, Sonia, Llombart-Cussac, Antonio, Camps Herrero, Carlos
Publicado no Mol Clin Oncol (2017)

Fulvestrant 500 mg Versus Anastrozole 1 mg for the First-Line Treatment of Advanced Breast Cancer: Overall Survival Analysis From the Phase II FIRST Study

Por Ellis, Matthew J., Llombart-Cussac, Antonio, Feltl, David, Dewar, John A., Jasiówka, Marek, Hewson, Nicola, Rukazenkov, Yuri, Robertson, John F.R.
Publicado no J Clin Oncol (2015)

The Value of Case Reports in Systematic Reviews from Rare Diseases. The Example of Enzyme Replacement Therapy (ERT) in Patients with Mucopolysaccharidosis Type II (MPS-II)

Por Sampayo-Cordero, Miguel, Miguel-Huguet, Bernat, Malfettone, Andrea, Pérez-García, José Manuel, Llombart-Cussac, Antonio, Cortés, Javier, Pardo, Almudena, Pérez-López, Jordi
Publicado no Int J Environ Res Public Health (2020)

Nobody dares stopping clinical research, not even COVID-19

Por Malfettone, Andrea, Di Cosimo, Serena, Pérez-García, José Manuel, García, Alicia, Sampayo-Cordero, Miguel, Mina, Leonardo, Herrero, Carolina, Llombart-Cussac, Antonio, Cortés, Javier
Publicado no NPJ Breast Cancer (2021)

Prognostic characteristics in hormone receptor-positive advanced breast cancer and characterization of abemaciclib efficacy

Por Di Leo, Angelo, O’Shaughnessy, Joyce, Sledge, George W., Martin, Miguel, Lin, Yong, Frenzel, Martin, Hardebeck, Molly C., Smith, Ian C., Llombart-Cussac, Antonio, Goetz, Matthew P., Johnston, Stephen
Publicado no NPJ Breast Cancer (2018)

Progress Against Solid Tumors in Danger: The Metastatic Breast Cancer Example

Por Cortés, Javier, Calvo, Emiliano, González-Martín, Antonio, Dawood, Shaheenah, Llombart-Cussac, Antonio, De Mattos-Arruda, Leticia, Gómez, Patricia, Silva, Orlando, Perez, Edith A., Rugo, Hope S., Lluch, Ana, Hortobagyi, Gabriel N.
Publicado no J Clin Oncol (2012)

Impact of SARS-CoV-2 Infection on Patients with Cancer: Retrospective and Transversal Studies in Spanish Population

Por Garde-Noguera, Javier, Fernández-Murga, M. Leonor, Giner-Bosch, Vicent, Dominguez-Márquez, Victoria, Sánchez, José García, Soler-Cataluña, Juan José, López Chuliá, Franscica, Honrubia, Beatriz, Piera, Nuria, Llombart-Cussac, Antonio
Publicado no Cancers (Basel) (2020)

Agreement between results of meta-analyses from case reports and clinical studies, regarding efficacy and safety of idursulfase therapy in patients with mucopolysaccharidosis type...

Por Sampayo-Cordero, Miguel, Miguel-Huguet, Bernat, Pardo-Mateos, Almudena, Malfettone, Andrea, Pérez-García, José, Llombart-Cussac, Antonio, Cortés, Javier, Moltó-Abad, Marc, Muñoz-Delgado, Cecilia, Pérez-Quintana, Marta, Pérez-López, Jordi
Publicado no Orphanet J Rare Dis (2019)

Differences in circulating γδ T cells in patients with primary colon cancer and relation with prognostic factors

Por Andreu-Ballester, Juan Carlos, Galindo-Regal, Lorena, Hidalgo-Coloma, Julia, Cuéllar, Carmen, García-Ballesteros, Carlos, Hurtado, Carolina, Uribe, Natalia, del Carmen Martín, María, Jiménez, Ana Isabel, López-Chuliá, Francisca, Llombart-Cussac, Antonio
Publicado no PLoS One (2020)

Inclusion of non-inferiority analysis in superiority-based clinical trials with single-arm, two-stage Simon's design

Por Sampayo-Cordero, Miguel, Miguel-Huguet, Bernat, Pérez-García, José, Páez, David, Guerrero-Zotano, Ángel L., Garde-Noguera, Javier, Aguirre, Elena, Holgado, Esther, López-Miranda, Elena, Huang, Xin, Malfettone, Andrea, Llombart-Cussac, Antonio, Cortés, Javier
Publicado no Contemp Clin Trials Commun (2020)

Trastuzumab Emtansine Plus Non-Pegylated Liposomal Doxorubicin in HER2-Positive Metastatic Breast Cancer (Thelma): A Single-Arm, Multicenter, Phase Ib Trial

Por López-Miranda, Elena, Pérez-García, José Manuel, Di Cosimo, Serena, Brain, Etienne, Ravnik, Maja, Escrivá-de-Romaní, Santiago, Vidal, Maria, Gligorov, Joseph, Borštnar, Simona, Calabuig, Laura, Sampayo-Cordero, Miguel, Malfettone, Andrea, Llombart-Cussac, Antonio, Suter, Thomas M., Cortés, Javier
Publicado no Cancers (Basel) (2020)

A polymorphism at the 3'-UTR region of the aromatase gene defines a subgroup of postmenopausal breast cancer patients with poor response to neoadjuvant letrozole

Por Garcia-Casado, Zaida, Guerrero-Zotano, Angel, Llombart-Cussac, Antonio, Calatrava, Ana, Fernandez-Serra, Antonio, Ruiz-Simon, Amparo, Gavila, Joaquin, Climent, Miguel A, Almenar, Sergio, Cervera-Deval, Jose, Campos, Josefina, Albaladejo, Carlos Vazquez, Llombart-Bosch, Antonio, Guillem, Vicente, Lopez-Guerrero, Jose A
Publicado em 2010

The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor–Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy—MONARCH 2: A Randomiz...

Por Sledge, George W., Toi, Masakazu, Neven, Patrick, Sohn, Joohyuk, Inoue, Kenichi, Pivot, Xavier, Burdaeva, Olga, Okera, Meena, Masuda, Norikazu, Kaufman, Peter A., Koh, Han, Grischke, Eva-Maria, Conte, PierFranco, Lu, Yi, Barriga, Susana, Hurt, Karla, Frenzel, Martin, Johnston, Stephen, Llombart-Cussac, Antonio
Publicado no JAMA Oncol (2019)

Safety, activity, and molecular heterogeneity following neoadjuvant non-pegylated liposomal doxorubicin, paclitaxel, trastuzumab, and pertuzumab in HER2-positive breast cancer (Opt...

Por Gavilá, Joaquín, Oliveira, Mafalda, Pascual, Tomás, Perez-Garcia, Jose, Gonzàlez, Xavier, Canes, Jordi, Paré, Laia, Calvo, Isabel, Ciruelos, Eva, Muñoz, Montserrat, Virizuela, Juan A., Ruiz, Isabel, Andrés, Raquel, Perelló, Antonia, Martínez, Jerónimo, Morales, Serafín, Marín-Aguilera, Mercedes, Martínez, Débora, Quero, Juan C., Llombart-Cussac, Antonio, Prat, Aleix
Publicado no BMC Med (2019)

Overall Survival of CDK4/6-Inhibitor–Based Treatments in Clinically Relevant Subgroups of Metastatic Breast Cancer: Systematic Review and Meta-Analysis

Por Schettini, Francesco, Giudici, Fabiola, Giuliano, Mario, Cristofanilli, Massimo, Arpino, Grazia, Del Mastro, Lucia, Puglisi, Fabio, De Placido, Sabino, Paris, Ida, De Placido, Pietro, Venturini, Sergio, De Laurentis, Michelino, Conte, PierFranco, Juric, Dejan, Llombart-Cussac, Antonio, Pusztai, Lajos, Prat, Aleix, Jerusalem, Guy, Di Leo, Angelo, Generali, Daniele
Publicado no J Natl Cancer Inst (2020)

SOLTI NeoPARP: a phase II randomized study of two schedules of iniparib plus paclitaxel versus paclitaxel alone as neoadjuvant therapy in patients with triple-negative breast cance...

Por Llombart-Cussac, Antonio, Bermejo, Begoña, Villanueva, Cristian, Delaloge, Suzette, Morales, Serafín, Balmaña, Judith, Amillano, Kepa, Bonnefoi, Hervé, Casas, Ana, Manso, Luis, Roché, Henri, Gonzalez-Santiago, Santiago, Gavilá, Joaquín, Sánchez-Rovira, Pedro, Di Cosimo, Serena, Harbeck, Nadia, Charpentier, Eric, Garcia-Ribas, Ignacio, Radosevic-Robin, Nina, Aura, Claudia, Baselga, Jose
Publicado no Breast Cancer Res Treat (2015)

Poly adenosine diphosphate ribose polymerase inhibitors (PARPi) induce autophagy-mediated drug resistance in ovarian cancer cells, xenografts and PDX models

Por Santiago-O’Farrill, Janice M., Weroha, S. John, Hou, Xiaonan, Oberg, Ann L., Heinzen, Ethan P., Maurer, Matthew J., Pang, Lan, Rask, Philip, Amaravadi, Ravi K., Becker, Sarah E., Romero, Ignacio, Rubió, M. Jesús, Matias-Guiu, X., Santacana, Maria, Llombart-Cussac, Antonio, Poveda, Andrés, Lu, Zhen, Bast, Robert C.
Publicado no Cancer (2019)

Survival impact of primary tumor resection in de novo metastatic breast cancer patients (GEICAM/El Alamo Registry)

Por Lopez-Tarruella, Sara, Escudero, M. J., Pollan, Marina, Martín, Miguel, Jara, Carlos, Bermejo, Begoña, Guerrero-Zotano, Angel, García-Saenz, José, Santaballa, Ana, Alba, Emilio, Andrés, Raquel, Martínez, Purificación, Calvo, Lourdes, Fernández, Antonio, Batista, Norberto, Llombart-Cussac, Antonio, Antón, Antonio, Lahuerta, Ainhara, de la Haba, Juan, López-Vega, José Manuel, Carrasco, E.
Publicado no Sci Rep (2019)

Phenotypic changes of HER2-positive breast cancer during and after dual HER2 blockade

Por Brasó-Maristany, Fara, Griguolo, Gaia, Pascual, Tomás, Paré, Laia, Nuciforo, Paolo, Llombart-Cussac, Antonio, Bermejo, Begoña, Oliveira, Mafalda, Morales, Serafín, Martínez, Noelia, Vidal, Maria, Adamo, Barbara, Martínez, Olga, Pernas, Sonia, López, Rafael, Muñoz, Montserrat, Chic, Núria, Galván, Patricia, Garau, Isabel, Manso, Luis, Alarcón, Jesús, Martínez, Eduardo, Gregorio, Sara, Gomis, Roger R., Villagrasa, Patricia, Cortés, Javier, Ciruelos, Eva, Prat, Aleix
Publicado no Nat Commun (2020)